乳腺癌中的C5aR2及其与临床病理特征的关系
Erum Khaliq1, Sumayyah Shawana1, Nighat Jamal2
1Department of Pathology, Bahria University Health Sciences Campus Karachi (BUHSCK), Karachi, Pakistan.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|December 9, 2024
概括
这项研究发现,乳腺癌中C5aR2表达与患者年龄,瘤等级和治疗反应有关. 在老年患者,高度瘤和治疗结果较差的患者中观察到更高的C5aR2水平.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 乳腺癌是全球重要的健康问题.
- C5aR2 (补充成分5a受体2) 是一种参与炎症过程的受体.
- 了解C5aR2在乳腺癌进展中的作用对于开发向疗法至关重要.
研究的目的:
- 研究乳腺癌患者C5aR2表达和各种临床病理参数之间的相关性.
- 确定C5aR2表达水平是否可以作为乳腺癌的预后标志物.
主要方法:
- 进行了一项观察性研究,涉及128名被诊断为乳腺癌的女性.
- 免疫组织化学 (IHC) 用于评估瘤和 stromal 细胞中的 C5aR2 表达,评估百分比和强度.
- 使用SPSS版本27的统计分析与临床病理特征相关联的C5aR2表达 (通过免疫反应评分 - IRS).
主要成果:
- 在90.6%的瘤细胞和53.1%的树皮细胞中检测到C5aR2表达,主要以细胞质局部化为主.
- 较高的C5aR2表达与较年长的年龄组,较高的瘤等级和阳性ER/PR/HER2和HER2状态相关.
- 与良好反应相比,治疗反应不佳的瘤表现出C5aR2表达的增加,并且在具有高细胞增殖率的瘤中注意到表达的增加,尽管与Ki67.7没有显著的关联.
结论:
- 瘤和 stromal C5aR2表达与乳腺癌的关键临床病理因素有关,包括年龄,等级,受体状态,增殖率和治疗后反应.
- 这些发现表明C5aR2可能在乳腺癌进展中发挥作用,并可能成为预后指标.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
217
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
15.8K
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328